VFA
RVMD icon

Valeo Financial Advisors’s Revolution Medicines RVMD Stock Holding History

Valeo Financial Advisors’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$206K Buy
+1,101
New +$161K ﹤0.01% 754

Other funds holding RVMD

Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
TE
Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return
WPC
Wedmont Private Capital West Chester, Pennsylvania $3.65B AUM 26.64% 1-Year Est. Return
II
IFM Investors Melbourne, Australia $15.1B AUM 40.57% 1-Year Est. Return
SAM
Shikiar Asset Management New York $396M AUM 41.06% 1-Year Est. Return
SCA
Sandy Cove Advisors Hingham, Massachusetts $400M AUM 27.68% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
SMDAM
Sumitomo Mitsui DS Asset Management Tokyo, Japan $14.5B AUM 37.68% 1-Year Est. Return
SWM
Spire Wealth Management Mclean, Virginia $3.31B AUM 38.78% 1-Year Est. Return

Valeo Financial Advisors's RVMD Position: Q2 2026 in Review

Valeo Financial Advisors opened a new position in Revolution Medicines (RVMD) in Q2 2026: 1,101 shares worth $206K. The stake represents ﹤0.01% of the portfolio and ranks #754 among its holdings.

93 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Valeo Financial Advisors held 1,101 shares of Revolution Medicines worth $206K as of Q2 2026.
  • Revolution Medicines was a new Valeo Financial Advisors position in Q2 2026.
  • Revolution Medicines made up ﹤0.01% of Valeo Financial Advisors's portfolio in Q2 2026, its #754 holding.
  • 93 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Valeo Financial Advisors's 13F filing for Q2 2026, filed 8 Jul 2026.